Castanospermine, a tetrahydroxylated alkaloid that inhibits beta-glucosidase and beta-glucocerebrosidase

Archives of Biochemistry and Biophysics
R SaulA D Elbein

Abstract

Castanospermine (1,6,7,8-tetrahydroxyoctahydroindolizine) was tested against a variety of commercially available glycosidases and found to be a potent inhibitor of almond emulsin beta-glucosidase, and also to inhibit fungal beta-xylosidase. This alkaloid was inactive on yeast alpha-glucosidase, alpha- or beta-galactosidase, alpha-mannosidase, beta-N-acetylhexosaminidase, beta-glucuronidase, alpha-L-fucosidase. Fifty-percent inhibition of beta-glucosidase required about 10 micrograms/ml of castanospermine. The amount of inhibition was uniform throughout the time course, and the inhibition with regard to substrate concentration (p-nitrophenyl-beta-D-glucopyranoside) appeared to be of the mixed type. Castanospermine was also a potent inhibitor of beta-glucocerebrosidase when assayed with fibroblast extracts using either a fluorimetric or a radioactive assay. Interestingly enough, castanospermine also inhibited the lysosomal alpha-glucosidase, and this inhibition required comparable levels of alkaloid to that required for inhibition of beta-glucocerebrosidase. However, a number of other lysosomal glycosidases were not sensitive to castanospermine (i.e., alpha- or beta-galactosidase, alpha- or beta-mannosidase, alpha- or beta-L-fuco...Continue Reading

References

May 1, 1975·Clinica Chimica Acta; International Journal of Clinical Chemistry·S P PetersR H Glew
Dec 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·A D ElbeinK Vosbeck

❮ Previous
Next ❯

Citations

Jul 1, 1987·Journal of Chemical Ecology·B C CampbellK C Jones
Jun 1, 1988·Journal of Chemical Ecology·K L Stevens, R J Molyneux
Jul 15, 1987·Biochemical Pharmacology·B R EllmersK M Robinson
Mar 28, 1994·FEBS Letters·H LannertF T Wieland
Mar 1, 1989·Journal of the Neurological Sciences·D O WillenborgW B Cowden
Aug 18, 1986·Life Sciences·A M ScofieldG W Fleet
Jan 1, 1987·Pharmacology & Therapeutics·R DatemaP A Romero
Jan 1, 1989·Pharmacology & Therapeutics·M J Humphries, K Olden
May 13, 1994·Brain Research. Developmental Brain Research·C AbotomeyC E Hill
Jun 24, 1985·Biochimica Et Biophysica Acta·U FuhrmannH Ploegh
Jun 9, 1995·Biochimica Et Biophysica Acta·O AndoK Tanzawa
Apr 1, 1989·Journal of Ethnopharmacology·J A Duke
Oct 22, 2013·Carbohydrate Research·Eduardo MarcaPedro Merino
Sep 11, 2002·Journal of Chromatography. a·Russell J MolyneuxSteven M Colegate
Jul 25, 2000·Journal of Ethnopharmacology·A TapiaG Schmeda-Hirschmann
Mar 16, 2013·Proceedings of the National Academy of Sciences of the United States of America·Nicole M OkeleyPeter D Senter
Jan 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·R SaulA D Elbein
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·B D WalkerJ Sodroski
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·K A WallA D Elbein
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A KarpasT W Rademacher
Aug 18, 2009·The Journal of Biological Chemistry·Ikuo HayashiTakeshi Iwatsubo
Apr 28, 2011·The Journal of Biological Chemistry·Kazuhiro ShiozakiTaeko Miyagi
Jan 26, 2008·Glycobiology·Isabelle Chantret, Stuart E H Moore
Jun 6, 2009·Glycobiology·Benjamin MimeeRichard R Bélanger
Mar 18, 2006·Beilstein Journal of Organic Chemistry·Olivia AndriuzziYves Le Merrer
Apr 20, 2001·Chemical & Pharmaceutical Bulletin·M ShibanoG Kusano

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.